Treatment and Surgical Management of CEAS

Because chronic enteropathy associated with SLCO2A1 (CEAS) is a genetic condition rather than a conventional autoimmune disorder, treating it requires a different approach than more common bowel diseases ^[1][2]. Many patients find it frustrating to try multiple medications that don’t seem to work, but this is often due to the unique biology of the disease ^[3][4].

CRITICAL WARNING: Do not stop or change any prescribed medications on your own. Even if these medications are not curing the CEAS, abruptly stopping steroids can be dangerous. Other drugs may be necessary for co-existing conditions, or may have been started while the diagnosis was uncertain. Always discuss changes with your prescribing doctor ^[5].

Management focuses on two main goals: supporting your body to replace what is being lost through the intestinal ulcers and managing the physical narrowings (strictures) that can develop over time ^[5][4].

Why Standard Meds Often Have Limited Benefit

In conditions like Crohn’s disease, the immune system is overactive, so doctors use drugs to “calm” it down ^[1]. However, in CEAS, the problem is a transport system defect for prostaglandins ^[6]. Because the root cause isn’t a conventional overactive immune system, many standard treatments often have limited or inconsistent benefit:

• Corticosteroids: Frequently fail to heal the ulcers or sustainably improve symptoms in CEAS ^[3][4].
• Biologics (Anti-TNF therapy): Drugs like infliximab or adalimumab, which are life-changing for many Crohn’s patients, often have limited benefit for those with CEAS ^[4][7].
• Immunomodulators: Medications like azathioprine have shown very little success in pediatric and adult case series ^[3][8].

Supportive Mainstays of Care

Since there is currently no established disease-modifying regimen that fixes the SLCO2A1 gene mutation, the standard of care is supportive management. This means doctors work to replace the blood and protein your body is losing through the ulcers ^[5][9].

• Iron Supplementation: Chronic blood loss leads to iron-deficiency anemia. While oral iron is often the first step, many patients require intravenous (IV) iron (such as ferric carboxymaltose) because it bypasses impaired gastrointestinal absorption and can more quickly improve energy levels and hemoglobin ^[5][10]. IV iron is individualized and not automatically required for everyone.
• Protein and Albumin Support: To combat hypoproteinemia (low protein), doctors may use albumin infusions in selected severe cases to temporarily reduce swelling. It is important to know that albumin is a temporary oncotic support measure, not a nutritional replacement or a treatment that stops the underlying protein loss ^[5].
• Enteral Nutrition: Specialized liquid diets (enteral nutrition) can sometimes help provide essential nutrients guided by a dietitian, though they do not necessarily heal the ulcers on their own ^[5][9]. Do not impose highly restrictive diets on yourself without professional guidance.

Managing Strictures

As ulcers heal, they can leave behind scar tissue that narrows the intestine, forming a stricture ^[11]. If a stricture starts to cause a blockage, your care team has two main options based on the stricture’s length, number, and location:

1. Endoscopic Balloon Dilation (EBD): If a stricture is reachable with an endoscope, a doctor can insert a small balloon and inflate it to widen the narrowed area ^[5][12]. This is a “bowel-preserving” option that can sometimes postpone surgery, but it carries risks of bleeding or bowel perforation and often requires repeat procedures ^[13][14].
2. Surgery: If a stricture is too tight, too long, or unreachable, surgery may be necessary. The most common procedures are segmental resection (removing the narrowed piece of bowel) or strictureplasty (a technique to widen the bowel without removing any tissue) ^[12][15].

The Reality of Recurrence

It is important to have an honest conversation with your surgeon about long-term outcomes. Because the underlying genetic cause of CEAS remains, new ulcers and strictures can form even after a successful operation ^[15][11].

Recurrence of strictures after surgery is common in CEAS observational series, and some patients may require multiple surgeries over their lifetime ^[15][3]. In one small observational study, about 28% of patients who initially managed their disease without surgery eventually required it as the condition progressed ^[11]. Your care team will monitor you closely with imaging to catch these narrowings early, with the goal of using the safest and most effective methods possible to keep your digestive tract open and functional ^[5][11].